These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32372588)

  • 1. Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.
    Incorvaia C; Ciprandi G; Nizi MC; Makri E; Ridolo E
    Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):245-257. PubMed ID: 32372588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in allergen immunotherapy as a treatment of asthma.
    Incorvaia C; Makri E; Ridolo E; Pellicelli I; Panella L
    Expert Rev Respir Med; 2019 Dec; 13(12):1161-1167. PubMed ID: 31581868
    [No Abstract]   [Full Text] [Related]  

  • 3. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New applications for sublingual immunotherapy in allergy.
    Incorvaia C; Mauro M; Cappelletti T; Pravettoni C; Leo G; Riario-Sforza GG
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):113-7. PubMed ID: 19519587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-specific sublingual immunotherapy for respiratory allergy.
    Passalacqua G; Canonica GW
    BioDrugs; 2001; 15(8):509-19. PubMed ID: 11543692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
    Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
    Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis.
    Meadows A; Kaambwa B; Novielli N; Huissoon A; Fry-Smith A; Meads C; Barton P; Dretzke J
    Health Technol Assess; 2013 Jul; 17(27):vi, xi-xiv, 1-322. PubMed ID: 23827204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose dependence of efficacy but not of safety in sublingual immunotherapy.
    Frati F; Incorvaia C; Marcucci F; Sensi L; Di Cara G; Puccinelli P; Dal Bo S
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):38-40. PubMed ID: 16700192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
    Kleine-Tebbe J; Ackermann-Simon J; Hanf G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen immunotherapy for respiratory allergy: to what extent can the risk of systemic reactions be reduced?
    Incorvaia C; Pucciarini F; Makri E; Gritti BL; Ridolo E
    Expert Opin Drug Saf; 2020 Jul; 19(7):843-848. PubMed ID: 32511028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment.
    Manzotti G; Riario-Sforza GG; Dimatteo M; Scolari C; Makri E; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2016 Nov; 48(6):224-227. PubMed ID: 27852426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
    J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy.
    Schulten V; Tripple V; Aasbjerg K; Backer V; Lund G; Würtzen PA; Sette A; Peters B
    Clin Exp Allergy; 2016 Mar; 46(3):439-48. PubMed ID: 26436865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.